Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study
Andreas A. Argyriou, Sofia Karteri, Jordi Bruna, Sara Mariotto, Marta Simó, Dimitrios Velissaris, Foteini Kalofonou, Guido Cavaletti, Sérgio Ferrari, Haralabos P. Kalofonos
Topics & Concepts
MedicineBiomarkerBreast cancerInternal medicineProspective cohort studyMontreal Cognitive AssessmentChemotherapyOncologyNeurotoxicityAdverse effectPaclitaxelChemotherapy regimenCancerGastroenterologyCognitive impairmentToxicityDiseaseChemistryBiochemistryCancer-related cognitive impairment studiesCancer Treatment and PharmacologyBrain Metastases and Treatment